(Q41753919)

8 October 2017

Downregulation of miR-22 acts as an unfavorable prognostic biomarker in osteosarcoma (English)

1 reference

8 October 2017

0 references

Guangji Wang

1

1 reference

8 October 2017

Ningjiang Shen

2

1 reference

8 October 2017

Liang Cheng

3

1 reference

8 October 2017

Jianping Lin

4

1 reference

8 October 2017

Kanghua Li

5

1 reference

8 October 2017

8 May 2015

1 reference

8 October 2017

1 reference

8 October 2017

36

1 reference

8 October 2017

7891-7895

1 reference

8 October 2017

10

1 reference

https://scigraph.springernature.com/pub.10.1007/s13277-015-3379-1

8 October 2017

0 references

cites work

6-Gingerol inhibits osteosarcoma cell proliferation through apoptosis and AMPK activation

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

MicroRNAs as promising biomarkers in cancer diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

Modulation of the osteosarcoma expression phenotype by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

MicroRNA profiling with correlation to gene expression revealed the oncogenic miR-17-92 cluster to be up-regulated in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

MicroRNA expression profiling during human cord blood-derived CD34 cell erythropoiesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

miR-22 in cardiac remodeling and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

MicroRNA 22 regulates cell cycle length in cerebellar granular neuron precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

Clinical significance of miR-22 expression in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

Down-regulated miR-22 as predictive biomarkers for prognosis of epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

MiR-22 suppresses the proliferation and invasion of gastric cancer cells by inhibiting CD151.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

A regulatory loop involving miR-22, Sp1, and c-Myc modulates CD147 expression in breast cancer invasion and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

Tumor suppressor miR-22 suppresses lung cancer cell progression through post-transcriptional regulation of ErbB3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

The microRNA profile of prostate carcinoma obtained by deep sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-3379-1

miR-22 inhibits proliferation and invasion in estrogen receptor α-positive endometrial endometrioid carcinomas cells

21 January 2018

1 reference

12 December 2020

Circulating miR-22, miR-24 and miR-34a as novel predictive biomarkers to pemetrexed-based chemotherapy in advanced non-small cell lung cancer

1 reference

12 December 2020

miR-22 inhibits osteosarcoma cell proliferation and migration by targeting HMGB1 and inhibiting HMGB1-mediated autophagy

1 reference

12 December 2020

Overexpression of miR-22 reverses paclitaxel-induced chemoresistance through activation of PTEN signaling in p53-mutated colon cancer cells

1 reference

12 December 2020

Upregulation of micro-ribonucleic acid-128 cooperating with downregulation of PTEN confers metastatic potential and unfavorable prognosis in patients with primary osteosarcoma

1 reference

12 December 2020

Differential microRNA expression by Solexa sequencing in the sera of ovarian cancer patients

1 reference

12 December 2020

miRNA expression profile in human osteosarcoma: role of miR-1 and miR-133b in proliferation and cell cycle control.

1 reference

12 December 2020

10.1007/S13277-015-3379-1

Identifiers

DOI

1 reference

Dimensions Publication ID

8 October 2017

0 references

1 reference